Hester Biosciences Limited (NSE:HESTERBIO)

Hester Biosciences Statistics

Total Valuation

NSE:HESTERBIO has a market cap or net worth of INR 15.89 billion. The enterprise value is 17.84 billion.

Market Cap	15.89B
Enterprise Value	17.84B

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	Aug 6, 2025

Share Statistics

Current Share Class	8.51M
Shares Outstanding	n/a
Shares Change (YoY)	-3.20%
Shares Change (QoQ)	+2.56%
Owned by Insiders (%)	63.75%
Owned by Institutions (%)	0.28%
Float	2.66M

Valuation Ratios

The trailing PE ratio is 28.55.

PE Ratio	28.55
Forward PE	n/a
PS Ratio	4.78
PB Ratio	4.32
P/TBV Ratio	4.53
P/FCF Ratio	34.30
P/OCF Ratio	24.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.18, with an EV/FCF ratio of 38.53.

EV / Earnings	32.07
EV / Sales	5.37
EV / EBITDA	19.18
EV / EBIT	24.07
EV / FCF	38.53

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.53.

Current Ratio	1.37
Quick Ratio	0.67
Debt / Equity	0.53
Debt / EBITDA	2.25
Debt / FCF	4.21
Interest Coverage	6.20

Financial Efficiency

Return on equity (ROE) is 16.56% and return on invested capital (ROIC) is 10.55%.

Return on Equity (ROE)	16.56%
Return on Assets (ROA)	6.36%
Return on Invested Capital (ROIC)	10.55%
Return on Capital Employed (ROCE)	12.90%
Weighted Average Cost of Capital (WACC)	6.35%
Revenue Per Employee	5.92M
Profits Per Employee	990,018
Employee Count	562
Asset Turnover	0.50
Inventory Turnover	1.15

Taxes

In the past 12 months, NSE:HESTERBIO has paid 183.52 million in taxes.

Income Tax	183.52M
Effective Tax Rate	24.20%

Stock Price Statistics

The stock price has increased by +7.56% in the last 52 weeks. The beta is 0.43, so NSE:HESTERBIO's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+7.56%
50-Day Moving Average	1,539.14
200-Day Moving Average	1,675.60
Relative Strength Index (RSI)	71.76
Average Volume (20 Days)	19,662

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:HESTERBIO had revenue of INR 3.33 billion and earned 556.39 million in profits. Earnings per share was 67.57.

Revenue	3.33B
Gross Profit	2.51B
Operating Income	677.77M
Pretax Income	758.36M
Net Income	556.39M
EBITDA	866.58M
EBIT	677.77M
Earnings Per Share (EPS)	67.57

Balance Sheet

The company has 65.38 million in cash and 1.95 billion in debt, with a net cash position of -1.88 billion.

Cash & Cash Equivalents	65.38M
Total Debt	1.95B
Net Cash	-1.88B
Net Cash Per Share	n/a
Equity (Book Value)	3.68B
Book Value Per Share	423.46
Working Capital	560.84M

Cash Flow

In the last 12 months, operating cash flow was 641.41 million and capital expenditures -178.28 million, giving a free cash flow of 463.13 million.

Operating Cash Flow	641.41M
Capital Expenditures	-178.28M
Depreciation & Amortization	188.81M
Net Borrowing	-361.27M
Free Cash Flow	463.13M
FCF Per Share	n/a

Margins

Gross margin is 75.36%, with operating and profit margins of 20.38% and 16.73%.

Gross Margin	75.36%
Operating Margin	20.38%
Pretax Margin	22.80%
Profit Margin	16.73%
EBITDA Margin	26.05%
EBIT Margin	20.38%
FCF Margin	13.92%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.39%.

Dividend Per Share	7.00
Dividend Yield	0.39%
Dividend Growth (YoY)	16.67%
Years of Dividend Growth	1
Payout Ratio	10.83%
Buyback Yield	3.20%
Shareholder Yield	3.59%
Earnings Yield	3.50%
FCF Yield	2.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7